All Updates

All Updates

icon
Filter
Funding
Mermade Seafoods raises USD 3.3 million in seed funding round
Cell-cultured Meat
Aug 29, 2022
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Yesterday
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Cell-cultured Meat

Cell-cultured Meat

Aug 29, 2022

Mermade Seafoods raises USD 3.3 million in seed funding round

Funding

  • Mermade Seafood, a Jerusalem-based cultivated seafood startup, raised USD 3.3 million in a seed funding round, with participation from OurCrowd, Fall Line Capital, and Sake Bosch along with a Dutch investment company among others.

  • The funding is expected to help the company hire stem cell and algae researchers for the development of its cultivated scallop product, which it expects to reach laboratory-scale production by 2023.

  • The company has developed a novel patent-pending circular method of production, “cytoponics,” which recycles bio-waste from cell-cultured meat production–made of water, ammonia, and carbon dioxide–to feed algae, which in turn is used as a growth medium. Mermade Seafood claims this method will result in products that are cost-effective with a high nutritional value. It further stated that this method can be used for an array of cell-based applications apart from cultivated meat, such as pharmaceuticals.

  • Mermade Seafood, founded in 2021, is a company focused on cultured seafood production with a focus on scallops as its initial product. The company is aiming to provide cultivated scallops at a much lower price point than what is available in the market, thereby increasing demand. 

<ul><li> AnalystQuickTake: Cell-cultured meat is heavily reliant on expensive growth media, making cell-cultured products much more expensive than conventional meat. Discovering a growth medium substitute to fetal bovine serum (FBS) is a key challenge for commercialization due to the high price tag it carries. Future Meat Technologies is another company that developed a technology to remove waste material from media, allowing the company to recycle parts of the media with the aim of reducing feed media input by almost 50%. In addition, it replaced FBS with molecules derived from Chinese hamster ovaries (CHO). Companies like Meatable are developing cell-cultured meat using pluripotent stem cells, which have the ability to convert to muscle or fat cells without FBS or CHO, in order to reduce production costs.</ul>

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.